TY - STD TI - Ali G-C, Guerchet M, Wu Y-T, Prince M, Prina M. Chapter 2: The global prevalence of dementia. In: Prince M, Guerchet M, Ali G-C, Wu Y-T, Prina M, editors. The Global Impact of Dementia. An analysis of prevalence, incidence, cost and trends. London: Alzheimer’s Disease International (ADI); 2015. p. 10–29. ID - ref1 ER - TY - JOUR AU - Cummings, J. PY - 2016 DA - 2016// TI - Drug development in Alzheimer’s disease: the path to 2025 JO - Alzheimers Res Ther VL - 8 UR - https://doi.org/10.1186/s13195-016-0207-9 DO - 10.1186/s13195-016-0207-9 ID - Cummings2016 ER - TY - JOUR AU - Vassar, R. AU - Citron, M. PY - 2000 DA - 2000// TI - Abeta-generating enzymes: recent advances in beta- and gamma-secretase research JO - Neuron VL - 27 UR - https://doi.org/10.1016/S0896-6273(00)00051-9 DO - 10.1016/S0896-6273(00)00051-9 ID - Vassar2000 ER - TY - JOUR AU - van Es, J. H. PY - 2005 DA - 2005// TI - Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells JO - Nature VL - 435 UR - https://doi.org/10.1038/nature03659 DO - 10.1038/nature03659 ID - van Es2005 ER - TY - JOUR AU - Olry, A. PY - 2005 DA - 2005// TI - Generation and characterization of mutant cell lines defective in gamma-secretase processing of notch and amyloid precursor protein JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M502199200 DO - 10.1074/jbc.M502199200 ID - Olry2005 ER - TY - JOUR AU - Tarassishin, L. PY - 2004 DA - 2004// TI - Processing of notch and amyloid precursor protein by gamma-secretase is spatially distinct JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.0408007101 DO - 10.1073/pnas.0408007101 ID - Tarassishin2004 ER - TY - JOUR AU - Sastre, M. PY - 2001 DA - 2001// TI - Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of notch JO - EMBO Rep VL - 2 UR - https://doi.org/10.1093/embo-reports/kve180 DO - 10.1093/embo-reports/kve180 ID - Sastre2001 ER - TY - JOUR AU - Klaver, D. W. PY - 2010 DA - 2010// TI - Is BACE1 a suitable therapeutic target for the treatment of Alzheimer’s disease? Current strategies and future directions JO - Biol Chem VL - 391 UR - https://doi.org/10.1515/bc.2010.089 DO - 10.1515/bc.2010.089 ID - Klaver2010 ER - TY - JOUR AU - Abramov, E. PY - 2009 DA - 2009// TI - Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses JO - Nat Neurosci VL - 12 UR - https://doi.org/10.1038/nn.2433 DO - 10.1038/nn.2433 ID - Abramov2009 ER - TY - JOUR AU - Gilman, S. PY - 2005 DA - 2005// TI - Clinical effects of Abeta immunization (AN1792) in patients with AD in AN interrupted trial JO - Neurology VL - 64 UR - https://doi.org/10.1212/01.WNL.0000159740.16984.3C DO - 10.1212/01.WNL.0000159740.16984.3C ID - Gilman2005 ER - TY - JOUR AU - Bayer, A. J. PY - 2005 DA - 2005// TI - Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD JO - Neurology VL - 64 UR - https://doi.org/10.1212/01.WNL.0000148604.77591.67 DO - 10.1212/01.WNL.0000148604.77591.67 ID - Bayer2005 ER - TY - JOUR AU - Holmes, C. PY - 2008 DA - 2008// TI - Long-term effects of Abeta42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61075-2 DO - 10.1016/S0140-6736(08)61075-2 ID - Holmes2008 ER - TY - JOUR AU - Laskowitz, D. T. AU - Kolls, B. J. PY - 2010 DA - 2010// TI - A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease JO - Neurology VL - 74 UR - https://doi.org/10.1212/WNL.0b013e3181e03844 DO - 10.1212/WNL.0b013e3181e03844 ID - Laskowitz2010 ER - TY - JOUR AU - Salloway, S. PY - 2009 DA - 2009// TI - A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease JO - Neurology VL - 73 UR - https://doi.org/10.1212/WNL.0b013e3181c67808 DO - 10.1212/WNL.0b013e3181c67808 ID - Salloway2009 ER - TY - JOUR AU - Ultsch, M. PY - 2016 DA - 2016// TI - Structure of Crenezumab complex with Abeta shows loss of beta-hairpin JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep39374 DO - 10.1038/srep39374 ID - Ultsch2016 ER - TY - JOUR AU - Bouter, Y. PY - 2015 DA - 2015// TI - Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against Ntruncated Abeta in sporadic Alzheimer disease cases and mouse models JO - Acta Neuropathol VL - 130 UR - https://doi.org/10.1007/s00401-015-1489-x DO - 10.1007/s00401-015-1489-x ID - Bouter2015 ER - TY - JOUR AU - The Lancet, N. PY - 2017 DA - 2017// TI - Solanezumab: too late in mild Alzheimer’ss disease? JO - Lancet Neurol VL - 16 UR - https://doi.org/10.1016/S1474-4422(16)30395-7 DO - 10.1016/S1474-4422(16)30395-7 ID - The Lancet2017 ER - TY - JOUR AU - Gandy, S. AU - Sano, M. PY - 2015 DA - 2015// TI - Alzheimer disease: Solanezumab-prospects for meaningful interventions in AD? JO - Nat Rev Neurol VL - 11 UR - https://doi.org/10.1038/nrneurol.2015.218 DO - 10.1038/nrneurol.2015.218 ID - Gandy2015 ER - TY - JOUR AU - Landen, J. W. PY - 2013 DA - 2013// TI - Safety and pharmacology of a single intravenous dose of ponezumab in subjects with mild-to-moderate Alzheimer disease: a phase I, randomized, placebo-controlled, double-blind, dose-escalation study JO - Clin Neuropharmacol VL - 36 UR - https://doi.org/10.1097/WNF.0b013e31827db49b DO - 10.1097/WNF.0b013e31827db49b ID - Landen2013 ER - TY - JOUR AU - Burstein, A. H. PY - 2013 DA - 2013// TI - Safety and pharmacology of ponezumab (PF-04360365) after a single 10-minute intravenous infusion in subjects with mild to moderate Alzheimer disease JO - Clin Neuropharmacol VL - 36 UR - https://doi.org/10.1097/WNF.0b013e318279bcfa DO - 10.1097/WNF.0b013e318279bcfa ID - Burstein2013 ER - TY - JOUR AU - La Porte, S. L. PY - 2012 DA - 2012// TI - Structural basis of C-terminal beta-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease JO - J Mol Biol VL - 421 UR - https://doi.org/10.1016/j.jmb.2011.11.047 DO - 10.1016/j.jmb.2011.11.047 ID - La Porte2012 ER - TY - JOUR AU - Carlson, C. PY - 2016 DA - 2016// TI - Amyloid-related imaging abnormalities from trials of solanezumab for Alzheimer's disease JO - Alzheimers Dement (Amst) VL - 2 ID - Carlson2016 ER - TY - JOUR AU - Salloway, S. PY - 2011 DA - 2011// TI - A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease JO - Neurology VL - 77 UR - https://doi.org/10.1212/WNL.0b013e3182309fa5 DO - 10.1212/WNL.0b013e3182309fa5 ID - Salloway2011 ER - TY - JOUR AU - Aisen, P. S. PY - 2011 DA - 2011// TI - Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase study) JO - Arch Med Sci VL - 7 UR - https://doi.org/10.5114/aoms.2011.20612 DO - 10.5114/aoms.2011.20612 ID - Aisen2011 ER - TY - JOUR AU - Greenberg, S. M. PY - 2006 DA - 2006// TI - A phase 2 study of tramiprosate for cerebral amyloid angiopathy JO - Alzheimer Dis Assoc Disord VL - 20 UR - https://doi.org/10.1097/01.wad.0000213845.28624.f4 DO - 10.1097/01.wad.0000213845.28624.f4 ID - Greenberg2006 ER - TY - JOUR AU - Gervais, F. PY - 2007 DA - 2007// TI - Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis JO - Neurobiol Aging VL - 28 UR - https://doi.org/10.1016/j.neurobiolaging.2006.02.015 DO - 10.1016/j.neurobiolaging.2006.02.015 ID - Gervais2007 ER - TY - JOUR AU - Karran, E. AU - Mercken, M. AU - De Strooper, B. PY - 2011 DA - 2011// TI - The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics JO - Nat Rev Drug Discov VL - 10 UR - https://doi.org/10.1038/nrd3505 DO - 10.1038/nrd3505 ID - Karran2011 ER - TY - JOUR AU - Nie, Q. AU - Du, X. G. AU - Geng, M. Y. PY - 2011 DA - 2011// TI - Small molecule inhibitors of amyloid beta peptide aggregation as a potential therapeutic strategy for Alzheimer's disease JO - Acta Pharmacol Sin VL - 32 UR - https://doi.org/10.1038/aps.2011.14 DO - 10.1038/aps.2011.14 ID - Nie2011 ER - TY - JOUR AU - Sevigny, J. PY - 2017 DA - 2017// TI - Addendum: the antibody aducanumab reduces Abeta plaques in Alzheimer's disease JO - Nature VL - 546 UR - https://doi.org/10.1038/nature22809 DO - 10.1038/nature22809 ID - Sevigny2017 ER - TY - JOUR AU - Sevigny, J. PY - 2016 DA - 2016// TI - The antibody aducanumab reduces Abeta plaques in Alzheimer's disease JO - Nature VL - 537 UR - https://doi.org/10.1038/nature19323 DO - 10.1038/nature19323 ID - Sevigny2016 ER - TY - JOUR AU - Patel, K. R. PY - 2015 DA - 2015// TI - Biogen's aducanumab raises hope that Alzheimer's can be treated at its source JO - Manag Care VL - 24 ID - Patel2015 ER - TY - JOUR AU - Karran, E. PY - 2015 DA - 2015// TI - Recent trial shows that solanezumab has disease modifying effects JO - BMJ VL - 351 UR - https://doi.org/10.1136/bmj.h4528 DO - 10.1136/bmj.h4528 ID - Karran2015 ER - TY - JOUR AU - Siemers, E. R. PY - 2016 DA - 2016// TI - Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer's disease patients JO - Alzheimers Dement VL - 12 UR - https://doi.org/10.1016/j.jalz.2015.06.1893 DO - 10.1016/j.jalz.2015.06.1893 ID - Siemers2016 ER - TY - JOUR AU - Barrera-Ocampo, A. AU - Lopera, F. PY - 2016 DA - 2016// TI - Amyloid-beta immunotherapy: the hope for Alzheimer disease? JO - Colomb Med (Cali) VL - 47 ID - Barrera-Ocampo2016 ER - TY - JOUR AU - Hardy, J. A. AU - Higgins, G. A. PY - 1992 DA - 1992// TI - Alzheimer’s disease: the amyloid cascade hypothesis JO - Science VL - 256 UR - https://doi.org/10.1126/science.1566067 DO - 10.1126/science.1566067 ID - Hardy1992 ER - TY - JOUR AU - Musiek, E. S. AU - Holtzman, D. M. PY - 2015 DA - 2015// TI - Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’ JO - Nat Neurosci VL - 18 UR - https://doi.org/10.1038/nn.4018 DO - 10.1038/nn.4018 ID - Musiek2015 ER - TY - JOUR AU - Wang, J. PY - 2017 DA - 2017// TI - A systemic view of Alzheimer disease - insights from amyloid-beta metabolism beyond the brain JO - Nat Rev Neurol VL - 13 UR - https://doi.org/10.1038/nrneurol.2017.111 DO - 10.1038/nrneurol.2017.111 ID - Wang2017 ER - TY - JOUR AU - Brier, M. R. PY - 2016 DA - 2016// TI - Tau and Abeta imaging, CSF measures, and cognition in Alzheimer's disease JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aaf2362 DO - 10.1126/scitranslmed.aaf2362 ID - Brier2016 ER - TY - JOUR AU - Morris, M. PY - 2015 DA - 2015// TI - Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice JO - Nat Neurosci VL - 18 UR - https://doi.org/10.1038/nn.4067 DO - 10.1038/nn.4067 ID - Morris2015 ER - TY - JOUR AU - Gauthier, S. PY - 2016 DA - 2016// TI - Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)31275-2 DO - 10.1016/S0140-6736(16)31275-2 ID - Gauthier2016 ER - TY - JOUR AU - Novak, P. PY - 2017 DA - 2017// TI - Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial JO - Lancet Neurol VL - 16 UR - https://doi.org/10.1016/S1474-4422(16)30331-3 DO - 10.1016/S1474-4422(16)30331-3 ID - Novak2017 ER - TY - STD TI - Li C, Gotz J. Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov. 2017; ID - ref42 ER - TY - JOUR AU - Zhang, B. PY - 2013 DA - 2013// TI - Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease JO - Cell VL - 153 UR - https://doi.org/10.1016/j.cell.2013.03.030 DO - 10.1016/j.cell.2013.03.030 ID - Zhang2013 ER - TY - JOUR AU - Guerreiro, R. PY - 2013 DA - 2013// TI - TREM2 variants in Alzheimer's disease JO - N Engl J Med VL - 368 UR - https://doi.org/10.1056/NEJMoa1211851 DO - 10.1056/NEJMoa1211851 ID - Guerreiro2013 ER - TY - JOUR AU - Song, W. PY - 2017 DA - 2017// TI - Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2016.07.004 DO - 10.1016/j.jalz.2016.07.004 ID - Song2017 ER - TY - JOUR AU - Colonna, M. AU - Wang, Y. PY - 2016 DA - 2016// TI - TREM2 variants: new keys to decipher Alzheimer disease pathogenesis JO - Nat Rev Neurosci VL - 17 UR - https://doi.org/10.1038/nrn.2016.7 DO - 10.1038/nrn.2016.7 ID - Colonna2016 ER - TY - JOUR AU - Bolos, M. AU - Perea, J. R. AU - Avila, J. PY - 2017 DA - 2017// TI - Alzheimer's disease as an inflammatory disease JO - Biomol Concepts VL - 8 UR - https://doi.org/10.1515/bmc-2016-0029 DO - 10.1515/bmc-2016-0029 ID - Bolos2017 ER - TY - JOUR AU - Hong, S. AU - Dissing-Olesen, L. AU - Stevens, B. PY - 2016 DA - 2016// TI - New insights on the role of microglia in synaptic pruning in health and disease JO - Curr Opin Neurobiol VL - 36 UR - https://doi.org/10.1016/j.conb.2015.12.004 DO - 10.1016/j.conb.2015.12.004 ID - Hong2016 ER - TY - JOUR AU - Paolicelli, R. C. PY - 2011 DA - 2011// TI - Synaptic pruning by microglia is necessary for normal brain development JO - Science VL - 333 UR - https://doi.org/10.1126/science.1202529 DO - 10.1126/science.1202529 ID - Paolicelli2011 ER - TY - JOUR AU - Bliss, T. V. AU - Collingridge, G. L. AU - Morris, R. G. PY - 2014 DA - 2014// TI - Synaptic plasticity in health and disease: introduction and overview JO - Philos Trans R Soc Lond Ser B Biol Sci VL - 369 UR - https://doi.org/10.1098/rstb.2013.0129 DO - 10.1098/rstb.2013.0129 ID - Bliss2014 ER - TY - JOUR AU - Chen, J. PY - 2017 DA - 2017// TI - Inhibition of AGEs/RAGE/rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-kappaB pathway JO - J Neuroimmunol VL - 305 UR - https://doi.org/10.1016/j.jneuroim.2017.02.010 DO - 10.1016/j.jneuroim.2017.02.010 ID - Chen2017 ER - TY - JOUR AU - Hirbec H, E. AU - Noristani, H. N. AU - Perrin, F. E. PY - 2017 DA - 2017// TI - Microglia Responses in Acute and Chronic Neurological Diseases: What Microglia-Specific Transcriptomic Studies Taught (and did Not Teach) Us JO - Front Aging Neurosci VL - 9 UR - https://doi.org/10.3389/fnagi.2017.00227 DO - 10.3389/fnagi.2017.00227 ID - Hirbec H2017 ER - TY - JOUR AU - Baruch, K. PY - 2016 DA - 2016// TI - PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease JO - Nat Med VL - 22 UR - https://doi.org/10.1038/nm.4022 DO - 10.1038/nm.4022 ID - Baruch2016 ER - TY - JOUR AU - Saresella, M. PY - 2012 DA - 2012// TI - A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease JO - Neurobiol Aging VL - 33 UR - https://doi.org/10.1016/j.neurobiolaging.2011.03.004 DO - 10.1016/j.neurobiolaging.2011.03.004 ID - Saresella2012 ER - TY - JOUR AU - Saresella, M. PY - 2010 DA - 2010// TI - PD1 negative and PD1 positive CD4+ T regulatory cells in mild cognitive impairment and Alzheimer's disease JO - J Alzheimers Dis VL - 21 UR - https://doi.org/10.3233/JAD-2010-091696 DO - 10.3233/JAD-2010-091696 ID - Saresella2010 ER - TY - JOUR AU - Jevtic, S. PY - 2017 DA - 2017// TI - The role of the immune system in Alzheimer disease: etiology and treatment JO - Ageing Res Rev VL - 40 UR - https://doi.org/10.1016/j.arr.2017.08.005 DO - 10.1016/j.arr.2017.08.005 ID - Jevtic2017 ER - TY - JOUR AU - McGeer, P. L. AU - McGeer, E. G. PY - 2015 DA - 2015// TI - Targeting microglia for the treatment of Alzheimer's disease JO - Expert Opin Ther Targets VL - 19 UR - https://doi.org/10.1517/14728222.2014.988707 DO - 10.1517/14728222.2014.988707 ID - McGeer2015 ER - TY - JOUR AU - Salter, M. W. AU - Stevens, B. PY - 2017 DA - 2017// TI - Microglia emerge as central players in brain disease JO - Nat Med VL - 23 UR - https://doi.org/10.1038/nm.4397 DO - 10.1038/nm.4397 ID - Salter2017 ER - TY - JOUR AU - Hasselmo, M. E. AU - Anderson, B. P. AU - Bower, J. M. PY - 1992 DA - 1992// TI - Cholinergic modulation of cortical associative memory function JO - J Neurophysiol VL - 67 UR - https://doi.org/10.1152/jn.1992.67.5.1230 DO - 10.1152/jn.1992.67.5.1230 ID - Hasselmo1992 ER - TY - JOUR AU - Fine, A. PY - 1997 DA - 1997// TI - Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys JO - Neuroscience VL - 81 UR - https://doi.org/10.1016/S0306-4522(97)00208-X DO - 10.1016/S0306-4522(97)00208-X ID - Fine1997 ER - TY - JOUR AU - Sarter, M. AU - Bruno, J. P. PY - 1997 DA - 1997// TI - Cognitive functions of cortical acetylcholine: toward a unifying hypothesis JO - Brain Res Brain Res Rev VL - 23 UR - https://doi.org/10.1016/S0165-0173(96)00009-4 DO - 10.1016/S0165-0173(96)00009-4 ID - Sarter1997 ER - TY - JOUR AU - Miranda, M. I. AU - Bermudez-Rattoni, F. PY - 1999 DA - 1999// TI - Reversible inactivation of the nucleus basalis magnocellularis induces disruption of cortical acetylcholine release and acquisition, but not retrieval, of aversive memories JO - Proc Natl Acad Sci U S A VL - 96 UR - https://doi.org/10.1073/pnas.96.11.6478 DO - 10.1073/pnas.96.11.6478 ID - Miranda1999 ER - TY - JOUR AU - Haam, J. AU - Yakel, J. L. PY - 2017 DA - 2017// TI - Cholinergic modulation of the hippocampal region and memory function JO - J Neurochem VL - 142 UR - https://doi.org/10.1111/jnc.14052 DO - 10.1111/jnc.14052 ID - Haam2017 ER - TY - JOUR AU - Brinkman, S. D. AU - Gershon, S. PY - 1983 DA - 1983// TI - Measurement of cholinergic drug effects on memory in Alzheimer's disease JO - Neurobiol Aging VL - 4 UR - https://doi.org/10.1016/0197-4580(83)90038-6 DO - 10.1016/0197-4580(83)90038-6 ID - Brinkman1983 ER - TY - JOUR AU - Summers, W. K. PY - 1986 DA - 1986// TI - Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type JO - N Engl J Med VL - 315 UR - https://doi.org/10.1056/NEJM198611133152001 DO - 10.1056/NEJM198611133152001 ID - Summers1986 ER - TY - JOUR AU - Summers, W. K. PY - 1981 DA - 1981// TI - Use of THA in treatment of Alzheimer-like dementia: pilot study in twelve patients JO - Biol Psychiatry VL - 16 ID - Summers1981 ER - TY - JOUR AU - Cheignon, C. PY - 2018 DA - 2018// TI - Oxidative stress and the amyloid beta peptide in Alzheimer's disease JO - Redox Biol VL - 14 UR - https://doi.org/10.1016/j.redox.2017.10.014 DO - 10.1016/j.redox.2017.10.014 ID - Cheignon2018 ER - TY - JOUR AU - Sultana, R. AU - Butterfield, D. A. PY - 2008 DA - 2008// TI - Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease: insight into the role of oxidative stress JO - Proteomics Clin Appl VL - 2 UR - https://doi.org/10.1002/prca.200780024 DO - 10.1002/prca.200780024 ID - Sultana2008 ER - TY - JOUR AU - Butterfield, D. A. PY - 2007 DA - 2007// TI - Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment JO - Free Radic Biol Med VL - 43 UR - https://doi.org/10.1016/j.freeradbiomed.2007.05.037 DO - 10.1016/j.freeradbiomed.2007.05.037 ID - Butterfield2007 ER - TY - JOUR AU - Mohmmad Abdul, H. PY - 2006 DA - 2006// TI - Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease JO - J Neurochem VL - 96 UR - https://doi.org/10.1111/j.1471-4159.2005.03647.x DO - 10.1111/j.1471-4159.2005.03647.x ID - Mohmmad Abdul2006 ER - TY - JOUR AU - Gibson, G. L. AU - Allsop, D. AU - Austen, B. M. PY - 2004 DA - 2004// TI - Induction of cellular oxidative stress by the beta-amyloid peptide involved in Alzheimer's disease JO - Protein Pept Lett VL - 11 UR - https://doi.org/10.2174/0929866043407101 DO - 10.2174/0929866043407101 ID - Gibson2004 ER - TY - JOUR AU - Butterfield, D. A. PY - 2002 DA - 2002// TI - Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists JO - J Alzheimers Dis VL - 4 UR - https://doi.org/10.3233/JAD-2002-4309 DO - 10.3233/JAD-2002-4309 ID - Butterfield2002 ER - TY - JOUR AU - Butterfield, D. A. AU - Lauderback, C. M. PY - 2002 DA - 2002// TI - Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress JO - Free Radic Biol Med VL - 32 UR - https://doi.org/10.1016/S0891-5849(02)00794-3 DO - 10.1016/S0891-5849(02)00794-3 ID - Butterfield2002 ER - TY - JOUR AU - Persson, T. AU - Popescu, B. O. AU - Cedazo-Minguez, A. PY - 2014 DA - 2014// TI - Oxidative stress in Alzheimer's disease: why did antioxidant therapy fail? JO - Oxidative Med Cell Longev VL - 2014 UR - https://doi.org/10.1155/2014/427318 DO - 10.1155/2014/427318 ID - Persson2014 ER - TY - JOUR AU - Teixeira, J. PY - 2013 DA - 2013// TI - Alzheimer's disease and antioxidant therapy: how long how far? JO - Curr Med Chem VL - 20 UR - https://doi.org/10.2174/1871523011320240001 DO - 10.2174/1871523011320240001 ID - Teixeira2013 ER - TY - JOUR AU - Caldwell, C. C. AU - Yao, J. AU - Brinton, R. D. PY - 2015 DA - 2015// TI - Targeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunities JO - Neurotherapeutics VL - 12 UR - https://doi.org/10.1007/s13311-014-0324-8 DO - 10.1007/s13311-014-0324-8 ID - Caldwell2015 ER - TY - JOUR AU - Daulatzai, M. A. PY - 2017 DA - 2017// TI - Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease JO - J Neurosci Res VL - 95 UR - https://doi.org/10.1002/jnr.23777 DO - 10.1002/jnr.23777 ID - Daulatzai2017 ER - TY - JOUR AU - Nasrallah, I. AU - Dubroff, J. PY - 2013 DA - 2013// TI - An overview of PET neuroimaging JO - Semin Nucl Med VL - 43 UR - https://doi.org/10.1053/j.semnuclmed.2013.06.003 DO - 10.1053/j.semnuclmed.2013.06.003 ID - Nasrallah2013 ER - TY - JOUR AU - Deverman, B. E. AU - Patterson, P. H. PY - 2009 DA - 2009// TI - Cytokines and CNS development JO - Neuron VL - 64 UR - https://doi.org/10.1016/j.neuron.2009.09.002 DO - 10.1016/j.neuron.2009.09.002 ID - Deverman2009 ER - TY - JOUR AU - Stephan, A. H. AU - Barres, B. A. AU - Stevens, B. PY - 2012 DA - 2012// TI - The complement system: an unexpected role in synaptic pruning during development and disease JO - Annu Rev Neurosci VL - 35 UR - https://doi.org/10.1146/annurev-neuro-061010-113810 DO - 10.1146/annurev-neuro-061010-113810 ID - Stephan2012 ER - TY - JOUR AU - Lui, H. PY - 2016 DA - 2016// TI - Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation JO - Cell VL - 165 UR - https://doi.org/10.1016/j.cell.2016.04.001 DO - 10.1016/j.cell.2016.04.001 ID - Lui2016 ER - TY - JOUR AU - Elmer, B. M. AU - McAllister, A. K. PY - 2012 DA - 2012// TI - Major histocompatibility complex class I proteins in brain development and plasticity JO - Trends Neurosci VL - 35 UR - https://doi.org/10.1016/j.tins.2012.08.001 DO - 10.1016/j.tins.2012.08.001 ID - Elmer2012 ER - TY - JOUR AU - Erickson, M. A. AU - Dohi, K. AU - Banks, W. A. PY - 2012 DA - 2012// TI - Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier JO - Neuroimmunomodulation VL - 19 UR - https://doi.org/10.1159/000330247 DO - 10.1159/000330247 ID - Erickson2012 ER - TY - JOUR AU - Banks, W. A. PY - 2015 DA - 2015// TI - The blood-brain barrier in neuroimmunology: Tales of separation and assimilation JO - Brain Behav Immun VL - 44 UR - https://doi.org/10.1016/j.bbi.2014.08.007 DO - 10.1016/j.bbi.2014.08.007 ID - Banks2015 ER - TY - JOUR AU - Collins, S. M. AU - Surette, M. AU - Bercik, P. PY - 2012 DA - 2012// TI - The interplay between the intestinal microbiota and the brain JO - Nat Rev Microbiol VL - 10 UR - https://doi.org/10.1038/nrmicro2876 DO - 10.1038/nrmicro2876 ID - Collins2012 ER - TY - JOUR AU - Cryan, J. F. AU - Dinan, T. G. PY - 2012 DA - 2012// TI - Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour JO - Nat Rev Neurosci VL - 13 UR - https://doi.org/10.1038/nrn3346 DO - 10.1038/nrn3346 ID - Cryan2012 ER - TY - JOUR AU - Sampson, T. R. AU - Mazmanian, S. K. PY - 2015 DA - 2015// TI - Control of brain development, function, and behavior by the microbiome JO - Cell Host Microbe VL - 17 UR - https://doi.org/10.1016/j.chom.2015.04.011 DO - 10.1016/j.chom.2015.04.011 ID - Sampson2015 ER - TY - JOUR AU - Bhattacharjee, S. AU - Lukiw, W. J. PY - 2013 DA - 2013// TI - Alzheimer's disease and the microbiome JO - Front Cell Neurosci VL - 7 UR - https://doi.org/10.3389/fncel.2013.00153 DO - 10.3389/fncel.2013.00153 ID - Bhattacharjee2013 ER - TY - JOUR AU - Belkaid, Y. AU - Harrison, O. J. PY - 2017 DA - 2017// TI - Homeostatic immunity and the microbiota JO - Immunity VL - 46 UR - https://doi.org/10.1016/j.immuni.2017.04.008 DO - 10.1016/j.immuni.2017.04.008 ID - Belkaid2017 ER - TY - JOUR AU - Belkaid, Y. AU - Hand, T. W. PY - 2014 DA - 2014// TI - Role of the microbiota in immunity and inflammation JO - Cell VL - 157 UR - https://doi.org/10.1016/j.cell.2014.03.011 DO - 10.1016/j.cell.2014.03.011 ID - Belkaid2014 ER - TY - JOUR AU - Tomkovich, S. AU - Jobin, C. PY - 2016 DA - 2016// TI - Microbiota and host immune responses: a love-hate relationship JO - Immunology VL - 147 UR - https://doi.org/10.1111/imm.12538 DO - 10.1111/imm.12538 ID - Tomkovich2016 ER - TY - JOUR AU - Agace, W. W. AU - McCoy, K. D. PY - 2017 DA - 2017// TI - Regionalized development and maintenance of the intestinal adaptive immune landscape JO - Immunity VL - 46 UR - https://doi.org/10.1016/j.immuni.2017.04.004 DO - 10.1016/j.immuni.2017.04.004 ID - Agace2017 ER - TY - JOUR AU - Erny, D. PY - 2015 DA - 2015// TI - Host microbiota constantly control maturation and function of microglia in the CNS JO - Nat Neurosci VL - 18 UR - https://doi.org/10.1038/nn.4030 DO - 10.1038/nn.4030 ID - Erny2015 ER - TY - JOUR AU - Ivanov, I. I. PY - 2009 DA - 2009// TI - Induction of intestinal Th17 cells by segmented filamentous bacteria JO - Cell VL - 139 UR - https://doi.org/10.1016/j.cell.2009.09.033 DO - 10.1016/j.cell.2009.09.033 ID - Ivanov2009 ER - TY - JOUR AU - Sudo, N. PY - 2004 DA - 2004// TI - Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice JO - J Physiol VL - 558 UR - https://doi.org/10.1113/jphysiol.2004.063388 DO - 10.1113/jphysiol.2004.063388 ID - Sudo2004 ER - TY - JOUR AU - O'Mahony, S. M. PY - 2015 DA - 2015// TI - Serotonin, tryptophan metabolism and the brain-gut-microbiome axis JO - Behav Brain Res VL - 277 UR - https://doi.org/10.1016/j.bbr.2014.07.027 DO - 10.1016/j.bbr.2014.07.027 ID - O'Mahony2015 ER - TY - JOUR AU - Praveen, V. AU - Praveen, S. PY - 2016 DA - 2016// TI - Microbiome-gut-brain Axis: a pathway for improving brainstem serotonin homeostasis and successful autoresuscitation in SIDS-A novel hypothesis JO - Front Pediatr VL - 4 ID - Praveen2016 ER - TY - JOUR AU - Jiang, X. G. PY - 2003 DA - 2003// TI - Research progress in anti-inflammation of vagus nerve and neurotransmitter ach JO - Zhongguo Wei Zhong Bing Ji Jiu Yi Xue VL - 15 ID - Jiang2003 ER - TY - JOUR AU - Das, U. N. PY - 2007 DA - 2007// TI - Vagus nerve stimulation, depression, and inflammation JO - Neuropsychopharmacology VL - 32 UR - https://doi.org/10.1038/sj.npp.1301286 DO - 10.1038/sj.npp.1301286 ID - Das2007 ER - TY - JOUR AU - Browning, K. N. AU - Verheijden, S. AU - Boeckxstaens, G. E. PY - 2017 DA - 2017// TI - The Vagus nerve in appetite regulation, mood, and intestinal inflammation JO - Gastroenterology VL - 152 UR - https://doi.org/10.1053/j.gastro.2016.10.046 DO - 10.1053/j.gastro.2016.10.046 ID - Browning2017 ER - TY - JOUR AU - de Haan, J. J. PY - 2010 DA - 2010// TI - Exploring the link between inflammation and the vagus nerve JO - J Intern Med VL - 267 UR - https://doi.org/10.1111/j.1365-2796.2009.02086.x DO - 10.1111/j.1365-2796.2009.02086.x ID - de Haan2010 ER - TY - JOUR AU - Hoeger, S. PY - 2010 DA - 2010// TI - Modulation of brain dead induced inflammation by vagus nerve stimulation JO - Am J Transplant VL - 10 UR - https://doi.org/10.1111/j.1600-6143.2009.02951.x DO - 10.1111/j.1600-6143.2009.02951.x ID - Hoeger2010 ER - TY - JOUR AU - Mirakaj, V. PY - 2014 DA - 2014// TI - Vagus nerve controls resolution and pro-resolving mediators of inflammation JO - J Exp Med VL - 211 UR - https://doi.org/10.1084/jem.20132103 DO - 10.1084/jem.20132103 ID - Mirakaj2014 ER - TY - JOUR AU - Gordon, J. I. PY - 2012 DA - 2012// TI - The human gut microbiota and undernutrition JO - Sci Transl Med VL - 4 UR - https://doi.org/10.1126/scitranslmed.3004347 DO - 10.1126/scitranslmed.3004347 ID - Gordon2012 ER - TY - JOUR AU - Mitchell, R. W. PY - 2011 DA - 2011// TI - Fatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cells JO - J Neurochem VL - 117 ID - Mitchell2011 ER - TY - JOUR AU - Frost, G. PY - 2014 DA - 2014// TI - The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism JO - Nat Commun VL - 5 UR - https://doi.org/10.1038/ncomms4611 DO - 10.1038/ncomms4611 ID - Frost2014 ER - TY - JOUR AU - Zhao, Y. AU - Dua, P. AU - Lukiw, W. J. PY - 2015 DA - 2015// TI - Microbial sources of amyloid and relevance to Amyloidogenesis and Alzheimer's disease (AD) JO - J Alzheimers Dis Parkinsonism VL - 5 ID - Zhao2015 ER - TY - JOUR AU - Schwartz, K. AU - Boles, B. R. PY - 2013 DA - 2013// TI - Microbial amyloids--functions and interactions within the host JO - Curr Opin Microbiol VL - 16 UR - https://doi.org/10.1016/j.mib.2012.12.001 DO - 10.1016/j.mib.2012.12.001 ID - Schwartz2013 ER - TY - JOUR AU - Hill, J. M. AU - Lukiw, W. J. PY - 2015 DA - 2015// TI - Microbial-generated amyloids and Alzheimer's disease (AD) JO - Front Aging Neurosci VL - 7 UR - https://doi.org/10.3389/fnagi.2015.00009 DO - 10.3389/fnagi.2015.00009 ID - Hill2015 ER - TY - JOUR AU - Quigley, E. M. M. PY - 2017 DA - 2017// TI - Microbiota-brain-gut Axis and neurodegenerative diseases JO - Curr Neurol Neurosci Rep VL - 17 UR - https://doi.org/10.1007/s11910-017-0802-6 DO - 10.1007/s11910-017-0802-6 ID - Quigley2017 ER - TY - JOUR AU - Cattaneo, A. PY - 2017 DA - 2017// TI - Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly JO - Neurobiol Aging VL - 49 UR - https://doi.org/10.1016/j.neurobiolaging.2016.08.019 DO - 10.1016/j.neurobiolaging.2016.08.019 ID - Cattaneo2017 ER - TY - JOUR AU - Park, A. M. PY - 2017 DA - 2017// TI - Helicobacter pylori and gut microbiota in multiple sclerosis versus Alzheimer's disease: 10 pitfalls of microbiome studies JO - Clin Exp Neuroimmunol VL - 8 UR - https://doi.org/10.1111/cen3.12401 DO - 10.1111/cen3.12401 ID - Park2017 ER - TY - JOUR AU - Chen, F. PY - 2016 DA - 2016// TI - Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs? JO - J Ethnopharmacol VL - 179 UR - https://doi.org/10.1016/j.jep.2015.12.031 DO - 10.1016/j.jep.2015.12.031 ID - Chen2016 ER - TY - JOUR AU - Zheng, X. PY - 2015 DA - 2015// TI - Thinking outside the brain for cognitive improvement: Is peripheral immunomodulation on the way? JO - Neuropharmacology VL - 96 UR - https://doi.org/10.1016/j.neuropharm.2014.06.020 DO - 10.1016/j.neuropharm.2014.06.020 ID - Zheng2015 ER - TY - JOUR AU - Yang, W. T. PY - 2017 DA - 2017// TI - Chinese herbal medicine for Alzheimer's disease: clinical evidence and possible mechanism of neurogenesis JO - Biochem Pharmacol VL - 141 UR - https://doi.org/10.1016/j.bcp.2017.07.002 DO - 10.1016/j.bcp.2017.07.002 ID - Yang2017 ER -